The atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies

Adv Enzyme Regul. 2002:42:173-9. doi: 10.1016/s0065-2571(01)00029-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Carrier Proteins / chemistry*
  • Humans
  • Lipid Metabolism
  • MAP Kinase Kinase 5
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Models, Biological
  • NF-kappa B / metabolism
  • Nerve Growth Factor / metabolism
  • Protein Binding
  • Protein Isoforms
  • Protein Kinase C / metabolism*
  • Protein Structure, Tertiary
  • Signal Transduction
  • Tumor Cells, Cultured
  • Zinc / metabolism

Substances

  • Antineoplastic Agents
  • Carrier Proteins
  • NF-kappa B
  • Protein Isoforms
  • Nerve Growth Factor
  • Protein Kinase C
  • MAP Kinase Kinase 5
  • MAP2K5 protein, human
  • Mitogen-Activated Protein Kinase Kinases
  • Zinc